Chronic liver disease is associated with increased operative risk of open-heart surgery. In this study, transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) carried high periprocedural mortality, but transfemoral TAVR appeared to be superior to SAVR in terms of long-term survival. Better risk stratification tools are needed for patients with liver dysfunction to avoid futile TAVR and SAVR procedures.
Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
Tarantini G.;Nai Fovino L.
2020
Abstract
Chronic liver disease is associated with increased operative risk of open-heart surgery. In this study, transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) carried high periprocedural mortality, but transfemoral TAVR appeared to be superior to SAVR in terms of long-term survival. Better risk stratification tools are needed for patients with liver dysfunction to avoid futile TAVR and SAVR procedures.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Treatment of aortic stenosis in patients with chronic liver disease Another.pdf
Accesso riservato
Tipologia:
Published (publisher's version)
Licenza:
Accesso privato - non pubblico
Dimensione
622.06 kB
Formato
Adobe PDF
|
622.06 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
